ATNM
Actinium Pharmaceuticals Inc
1.10$
+1.9%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 99.9% | 99.8% | 97.9% | 99.6% | 99.4% | 97.3% | 96.2% | 86.4% | 97.8% | 99.2% | 97.2% | 96.1% | 96.9% | 95.4% | |
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 97.1% | 96.0% | 88.6% | 96.4% | 91.1% | 94.9% | 91.8% | 79.3% | 95.8% | 96.8% | 95.4% | 94.1% | 94.8% | 92.7% | |
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 97.1% | 96.0% | 88.8% | 96.4% | 91.1% | 94.9% | 91.8% | 79.3% | 95.8% | 96.8% | 95.4% | 94.1% | 94.8% | 92.7% | |
| – | – | – | – | – | 158,556.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | 0.1% | 0.2% | 1.7% | 0.4% | 0.4% | 0.3% | 0.8% | 9.8% | 1.6% | 0.8% | 2.6% | – | – | – | |
| 4,049.4% | 616.2% | 3,434.6% | 4,637.8% | 63,178.7% | 56,319.3% | 80.2% | 127.0% | 125.4% | 17.4% | 20.1% | 25.4% | 40.8% | 51.6% | 7.6% | 8.5% | 41.8% | 55.3% | 57.4% | 84.9% | |
| 937.8% | 57.2% | 1,188.1% | 1,409.0% | 24,040.7% | 17,540.7% | 80.2% | 127.0% | 125.4% | 17.4% | 20.1% | 25.4% | 40.7% | 45.8% | 7.2% | 8.5% | 9.3% | 10.4% | 10.6% | 15.4% | |
| – | – | – | – | – | 82,908.7% | 2.4% | 2.7% | 3.7% | 1.0% | 1.3% | 0.1% | 1.7% | 6.4% | 0.6% | 0.4% | 0.4% | 0.7% | 0.8% | 1.4% | |
| 751.1% | 36.6% | 557.3% | 636.3% | 9,129.3% | 429,674.0% | 15.5% | 6.6% | 30.2% | 5.5% | 18.6% | 25.4% | 39.0% | 39.4% | 6.5% | 6.9% | 8.9% | 9.8% | 9.8% | – | |
| -3,949.4% | -516.2% | -3,334.6% | -4,537.8% | -63,078.7% | -56,219.3% | 19.8% | -27.0% | -25.4% | 82.6% | 79.9% | 74.6% | 59.2% | 48.4% | 92.4% | 91.5% | 58.2% | 44.7% | 42.6% | 15.1% | |
| -41,596.4% | -3,243.3% | -11,244.2% | -12,805.2% | -180,035.3% | -173,176.0% | -963.0% | -1,153.7% | -1,205.0% | -422.1% | -606.1% | -889.7% | -1,255.0% | -1,788.8% | -347.9% | -318.1% | -252.9% | -414.5% | -488.7% | -791.3% | |
| 16,522.1% | 5,780.0% | 16,764.2% | 17,522.6% | 247,886.0% | 17,817.3% | 0.6% | 13.2% | 12.1% | 4.8% | 7.2% | 12.1% | 23.7% | 42.6% | 18.3% | 25.6% | 21.1% | 32.7% | 39.1% | 60.3% |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.